NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
November 19, 2024 — Eric Hannelius, a seasoned fintech leader, has made a significant donation to The Superhumans Center, an innovative orthopedic clinic dedicated to the treatment and rehabilitation of war victims. This contribution underscores his commitment to leveraging technology and resources to support transformative healthcare solutions.
November 19, 2024 — Lorati Company Limited has introduced a groundbreaking advancement in the treatment of age-related macular degeneration (AMD) with its nano-grade eye drops, potentially offering hope to those suffering from this condition.
November 18, 2024 — The biotechnology industry is booming, with a global market valued at $1.55 trillion in 2023. Impact BioMedical Inc. (NYSEAmerican: IBO) emerges as a promising player committed to advancing healthcare innovation and targeting chronic diseases with patented breakthroughs.
November 18, 2024 — WRZ introduces the 'Alpha Diet,' a popular weight management solution that has gained traction among celebrities and influencers. This innovative formula offers a non-intrusive, everyday way to support health and wellness journeys.
November 18, 2024 — Discover the rising popularity of the innovative Alpha Diet among U.S. models and celebrities. Learn how this simple yet effective weight management solution is gaining traction in the health and wellness industry.
November 17, 2024 — A groundbreaking study presented at the American Heart Association’s Scientific Sessions 2024 reveals that reconditioned pacemakers are as safe and effective as new ones, potentially providing affordable options for heart patients in low- and middle-income countries.
November 17, 2024 — Electronic nudge for flu vaccination improves rates, especially for heart attack survivors. Low-cost, scalable strategy to encourage annual influenza vaccination should be considered globally to improve vaccination rates across health care systems and countries.
November 17, 2024 — New study presented at the American Heart Association’s Scientific Sessions 2024 shows that a combination of two blood pressure-lowering medications in a single pill is equally effective in reducing blood pressure among adults in India. The findings have important implications for South Asian adults in the U.S., as well as for simplifying medication regimens for people with hypertension.
November 17, 2024 — New study reveals the potential of spironolactone in reducing heart failure risk after heart attack, presenting promising implications for post-heart attack care and treatment.
November 17, 2024 — Edoxaban, an oral anticoagulant, found equally effective as warfarin in preventing stroke and blood clots after heart valve replacement surgery. This has the potential to simplify treatment and improve patients' quality of life.
November 17, 2024 — A large-scale clinical trial presented at the American Heart Association’s Scientific Sessions 2024 found that intravenous infusion of exenatide during heart surgeries involving bypass did not significantly reduce the risk of death, stroke or organ failure. The study challenges the previous belief that exenatide could offer significant benefits in reducing complications during and after cardiac surgery.
November 16, 2024 — Using artificial intelligence to interpret echocardiograms may lead to faster diagnosis and treatment of heart conditions, improving patient outcomes and potentially saving lives. PanEcho's ability to accurately assess all major findings from any set of echocardiography videos has the potential to streamline the diagnostic process and make medical care more accessible.
November 16, 2024 — Pharmacists receiving feedback and educational resources saw a significant increase in managing heart failure and adjusting heart failure medications, as revealed in a study presented at the American Heart Association’s Scientific Sessions 2024. The findings underscore the potential for real-time feedback to improve heart failure and chronic disease management.
November 16, 2024 — Study reveals that prescribing anti-clotting medications to younger adults with AFib and no other risk factors for stroke does not reduce the risk of cognitive decline, stroke, or TIA. The findings challenge current treatment guidelines and may impact healthcare decisions for this patient population.
November 16, 2024 — New study reveals potential benefits of ablation treatment over medication for heart attack survivors with rapid heart rhythms. The findings could change the approach to treatment, offering more effective and less invasive options for better patient outcomes.
November 16, 2024 — An intensive treatment approach to lowering high systolic blood pressure in people with Type 2 diabetes reduces the risk of heart attack, stroke, heart failure and death due to cardiovascular disease. The study's findings provide valuable insights for healthcare professionals and patients, potentially leading to a more intensive systolic blood pressure target for the prevention of major cardiovascular events in this at-risk population.
November 15, 2024 — REM Holdings, Inc. provides an update on the delayed launch of the Deltawave product, projecting its introduction by the end of January 2025. The news sheds light on the company's commitment to compliance and the potential impact of the new product on the market.
November 15, 2024 — Federal lawsuit filed against Elanco Animal Health Inc. and specific executives for false and misleading statements. Investors urged to submit losses now. Whistleblowers encouraged to come forward.
November 15, 2024 — Dr. Loraine Lovejoy-Evans' book, No Nursing Home For Me!, offers practical and actionable steps to manage pain, improve mobility, and enhance overall well-being, helping older adults avoid nursing home care.
November 14, 2024 — Acadia Healthcare Company (NASDAQ: ACHC) faces securities class action lawsuits after allegations of false/misleading statements and harmful practices. Investors urged to submit losses. Impacting corporate accountability in healthcare.